Mineralys Therapeutics, Inc. Common Stock (MLYS) Annual Income Statement (USD)
MLYS Quarterly Financials (USD)
Frequently Asked Questions About Mineralys Therapeutics, Inc. Common Stock (MLYS) Stock
Mineralys Therapeutics, Inc. Common Stock's (MLYS) last reported annual revenue was USD 0.00.
Mineralys Therapeutics, Inc. Common Stock's (MLYS) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Mineralys Therapeutics, Inc. Common Stock's(MLYS) is not profitable as of its last reported annual financials.
The net profit margin for Mineralys Therapeutics, Inc. Common Stock's(MLYS) from its laster reported year is N/A
The return on equity (ROE) for Mineralys Therapeutics, Inc. Common Stock's(MLYS) from its last reported annual financials is : N/A
The return on assets (ROA) for Mineralys Therapeutics, Inc. Common Stock's(MLYS) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for Mineralys Therapeutics, Inc. Common Stock's(MLYS) from its last reported annual financials is : N/A
The Debt to Equity ratio for Mineralys Therapeutics, Inc. Common Stock's(MLYS) from its last reported annual financials is : N/A
The dividend yield for Mineralys Therapeutics, Inc. Common Stock's(MLYS) from its laster reported year is N/A
Mineralys Therapeutics, Inc. Common Stock's(MLYS) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MLYS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
